APA (7th ed.) Citation

WJE, S., CA, d. U., WJR, R., I, A. A., JM, M., CV, E. K., . . . FA, K. (2025). Thrombectomy in high-risk pulmonary embolism - device versus thrombolysis: Rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial. Thrombosis research, 255, 109420. https://doi.org/10.1016/j.thromres.2025.109420

Chicago Style (17th ed.) Citation

WJE, Stenger, et al. "Thrombectomy in High-risk Pulmonary Embolism - Device Versus Thrombolysis: Rationale and Design of the TORPEDO-NL Investigator-initiated, Academically-sponsored, Multicenter, Open-label Randomized Controlled Trial." Thrombosis Research 255 (2025): 109420. https://doi.org/10.1016/j.thromres.2025.109420.

MLA (9th ed.) Citation

WJE, Stenger, et al. "Thrombectomy in High-risk Pulmonary Embolism - Device Versus Thrombolysis: Rationale and Design of the TORPEDO-NL Investigator-initiated, Academically-sponsored, Multicenter, Open-label Randomized Controlled Trial." Thrombosis Research, vol. 255, 2025, p. 109420, https://doi.org/10.1016/j.thromres.2025.109420.